Penn Medicine Provider
Gastroenterology
Bryson Katona, MD, PhD
5.0
(229)
Accepting new patients
Sees patients age 18 and up
Penn Gastroenterology Perelman

About me

  • Director, Gastrointestinal Cancer Genetics Program
  • Director, Lynch Syndrome Program
  • Director, Gastrointestinal Cancer Risk Evaluation Program
  • Member, Abramson Cancer Center
  • Jeffery and Cynthia King Assistant Professor of Lynch Syndrome Research
  • Assistant Professor of Genetics

Dr. Katona is a physician-scientist specializing in risk assessment and management of hereditary Gastrointestinal Cancer predisposition syndromes. At Penn Medicine’s Abramson Cancer Center, he serves as the Director of the Gastrointestinal Cancer Genetics Program and as the Director of the Lynch Syndrome Program.

Education and training

  • Medical School: Washington University in St. Louis
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

229 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

March 2025
5.0
5.0
listens
March 2025
5.0
5.0
i was very impressed with the thoughtful, informative care i received.
March 2025
5.0
5.0
wonderful patient care
March 2025
5.0
5.0
i would highly recommend dr. katona.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Katona is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Katona BW, Lubinski J, Pal T, Huzarski T, Foulkes WD, Moller P, Eisen A, Randall Armel S, Neuhausen SL, Raj R, Aeilts A, Singer CF, Bordeleau L, Karlan B, Olopade O, Tung N, Zakalik D, Kotsopoulos J, Fruscio R, Eng C, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutation , Cancer, 131: 2025,e35666


Mirda D, Dungan M, Ren Y, Li H, Katona BW. Colorectal Neoplasia Detection Rates in Lynch Syndrome , Cancers (Basel), 16: 2024,4021


Phung L, Wood E, Egleston B, Hoffman-Andrews L, Ofidis D, Howe S, Mim R, Griffin H, Fetzer D, Owens A, Domchek S, Pyeritz R, Katona B, Kallish S, Sirugo G, Weaver J, Nathanson KL, Rader DJ, Bradbury AR. Facilitating return of actionable genetic research results from a biobank repository: Participant uptake and utilization of digital interventions , HGG Adv, 5: 2024,100346


Cheng HH, Shevach JW, Castro E, Couch FJ, Domchek SM, Eeles RA, Giri VN, Hall MJ, King MC, Lin DW, Loeb S, Morgan TM, Offit K, Pritchard CC, Schaeffer EM, Szymaniak BM, Vassy JL, Katona BW, Maxwell KN. BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review , JAMA Oncol, 10: 2024,1272-1281


Majer AD, Hua X, Katona BW. Menin in Cancer , Genes (Basel), 15(9): 2024,1231


Ness RM, Llor X, Abbass MA, Bishu S, Chen CT, Cooper G, Early DS, Friedman M, Fudman D, Giardiello FM, Glaser K, Gurudu S, Hall M, Huang LC, Issaka R, Katona B, Kidambi T, Lazenby AJ, Maratt J, Markowitz AJ, Marsano J, May FP, Mayer RJ, Olortegui K, Patel S, Peter S, Porter LD, Shafi M, Stanich PP, Terdiman J, Vu P, Weiss JM, Wood E, Cassara CJ, Sambandam V. NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024 , J Natl Compr Canc Netw, 22(7): 2024,438-446


Blackford AL, Canto MI, Dbouk M, Hruban RH, Katona BW, Chak A, Brand RE, Syngal S, Farrell J, Kastrinos F, Stoffel EM, Rustgi A, Klein AP, Kamel I, Fishman EK, He J, Burkhart R, Shin EJ, Lennon AM, Goggins M. Pancreatic Cancer Surveillance and Survival of High-Risk Individuals , JAMA Oncol, 10: 2024,1087-1096


Niccum BA, Coughlin S, Clay D, Heiman J, Buckley KH, Dungan M, Daniel MG, Ruiz J, Maxwell KN, Domchek SM, Leung G, Ahmad NA, Ginsberg GG, Kochman ML, Katona BW. Prevalence of H. pylori and Gastric Intestinal Metaplasia in BRCA1 and BRCA2 Carriers , Cancer Prev Res (Phila), 17: 2024,305-309


Cappadocia J, Aiello LB, Kelley MJ, Katona BW, Maxwell KN; Penn Medicine BioBank, Regeneron Genetics Center. PMS2CL interference leading to erroneous identification of a pathogenic PMS2 variant in Black patients , Genet Med Open, 2: 2024,101858


Wang L, Levinson R, Mezzacappa C, Katona BW. Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer , Fam Cancer, 23(3): 2024,351–360


View all publications